Paper778304
JC Papovavirus in progressive multifocal leukoencephalopathy.
Padgett BL and 4 others. J Infect Dis, 1976. Cited by 130 papers, by iCite.
Cite this record
ConductScience Library. JC Papovavirus in progressive multifocal leukoencephalopathy. Papers, record 778304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/778304
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukoencephalopathy, Progressive Multifocal | Major topic |
| Papillomaviridae | Major topic |
| Polyomaviridae | Major topic |
| Adult | |
| Antigens, Viral | |
| Brain | |
| Cells, Cultured | |
| Cytopathogenic Effect, Viral | |
| Female | |
| Fluorescent Antibody Technique | |
| Hemagglutination, Viral | |
| Humans | |
| Male | |
| Middle Aged | |
| Serotyping | |
| Virus Cultivation |
Source PubMed
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37659983 | Revisiting JC virus and progressive multifocal leukoencephalopathy. | J Neurovirol | 2023 | https://conductscience.org/library/papers/37659983 | PubMed |
| 37239927 | An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239927 | PubMed |
| 35239145 | A human-derived 3D brain organoid model to study JC virus infection. | J Neurovirol | 2022 | https://conductscience.org/library/papers/35239145 | PubMed |
| 34696366 | IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform. | Viruses | 2021 | https://conductscience.org/library/papers/34696366 | PubMed |
| 31996425 | CD8 T Cells and STAT1 Signaling Are Essential Codeterminants in Protection from Polyomavirus Encephalopathy. | J Virol | 2020 | https://conductscience.org/library/papers/31996425 | PubMed |
| 30955497 | Intra-patient viral evolution in polyomavirus-related diseases. | Philos Trans R Soc Lond B Biol Sci | 2019 | https://conductscience.org/library/papers/30955497 | PubMed |
| 26719788 | Tracing Jomon and Yayoi ancestries in Japan using ALDH2 and JC virus genotype distributions. | Investig Genet | 2015 | https://conductscience.org/library/papers/26719788 | PubMed |
| 25589241 | Polyomavirus T antigens activate an antiviral state. | Virology | 2015 | https://conductscience.org/library/papers/25589241 | PubMed |
| 25155602 | Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25155602 | PubMed |
| 24507517 | Infections and multiple sclerosis. | Handb Clin Neurol | 2014 | https://conductscience.org/library/papers/24507517 | PubMed |
| 24079660 | Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. | Virol J | 2013 | https://conductscience.org/library/papers/24079660 | PubMed |
| 24052414 | Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression. | J Neuroimmune Pharmacol | 2013 | https://conductscience.org/library/papers/24052414 | PubMed |
| 23700470 | Detection of JC virus-specific immune responses in a novel humanized mouse model. | PLoS One | 2013 | https://conductscience.org/library/papers/23700470 | PubMed |
| 23308224 | Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma. | PLoS One | 2013 | https://conductscience.org/library/papers/23308224 | PubMed |
| 19997600 | JC virus mediates invasion and migration in colorectal metastasis. | PLoS One | 2009 | https://conductscience.org/library/papers/19997600 | PubMed |
| 19258267 | Identification and characterization of mefloquine efficacy against JC virus in vitro. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19258267 | PubMed |
| 17531143 | High prevalence of human polyomavirus JC VP1 gene sequences in pediatric malignancies. | Cell Mol Biol (Noisy-le-grand) | 2007 | https://conductscience.org/library/papers/17531143 | PubMed |
| 16398941 | Comparison of real-time PCR and hemagglutination assay for quantitation of human polyomavirus JC. | Virol J | 2006 | https://conductscience.org/library/papers/16398941 | PubMed |
| 16097849 | AIDS-associated progressive multifocal leukoencephalopathy : current management strategies. | CNS Drugs | 2005 | https://conductscience.org/library/papers/16097849 | PubMed |
| 11517409 | Immune response in progressive multifocal leukoencephalopathy: an overview. | J Neurovirol | 2001 | https://conductscience.org/library/papers/11517409 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/778304
GET https://conductscience.org/api/papers/v1/778304/cited_by?page=2